For the year ending 2025-12-31, AUPH has $751,587K in assets. $170,256K in debts.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash, cash equivalents and restricted cash | 80,213 | |||
| Short-term investments | 317,784 | |||
| Accounts receivable, net | 41,454 | |||
| Inventory | 45,690 | |||
| Prepaid expenses and deposits | 5,746 | |||
| Other current assets | 1,080 | |||
| Total current assets | 491,967 | |||
| Deferred tax assets, net | 176,194 | |||
| Finance right-of-use lease assets | 73,865 | |||
| Intangible assets, net | 3,761 | |||
| Operating right-of-use lease assets | 3,596 | |||
| Property and equipment, net | 2,111 | |||
| Other noncurrent assets | 93 | |||
| Total assets | 751,587 | |||
| Accounts payable | 3,313 | |||
| Accrued expenses | 66,621 | |||
| Finance lease liabilities, current portion | 16,523 | |||
| Deferred revenue | 3,720 | |||
| Operating lease liabilities, current portion | 1,067 | |||
| Other current liabilities | 2,480 | |||
| Total current liabilities | 93,724 | |||
| Finance lease liabilities, less current portion | 52,322 | |||
| Deferred revenue, less current portion | 12,648 | |||
| Deferred compensation and other noncurrent liabilities | 6,662 | |||
| Operating lease liabilities, less current portion | 4,900 | |||
| Total liabilities | 170,256 | |||
| Common shares - no par value, unlimited shares authorized, 132,323 and 140,883 shares issued and outstanding at december 31, 2025 and 2024, respectively | 1,120,035 | |||
| Additional paid-in capital | 111,263 | |||
| Accumulated other comprehensive loss | -599 | |||
| Accumulated deficit | -649,368 | |||
| Total shareholders' equity | 581,331 | |||
| Total liabilities and shareholders' equity | 751,587 | |||
Aurinia Pharmaceuticals Inc. (AUPH)
Aurinia Pharmaceuticals Inc. (AUPH)